Literature DB >> 25744772

Predictors of mortality in patients with rheumatoid arthritis in Lithuania: Data from a cohort study over 10 years.

Jolanta Dadonienė1, Sigita Stropuvienė2, Rimantas Stukas3, Algirdas Venalis2, Tuulikki Sokka-Isler4.   

Abstract

BACKGROUND AND
OBJECTIVE: Increased mortality and shorter survival among rheumatoid arthritis (RA) patients are recognized but not fully explained. This cohort study aimed to identify predictors of mortality among RA patients at a tertiary clinical setting.
MATERIALS AND METHODS: Patients with RA were recruited during 1998-2003 and followed up until April 1, 2012, or death whichever happened first. Baseline variables included sociodemographic and disease characteristics, and comorbidities. Cox regression and hazard risk (HR) were computed to estimate risks for mortality.
RESULTS: One hundred ninety-one patients were included into the study, 186 patients were eligible for the analysis and of these 131 patients (70.4%) completed the entire period of followed-up while 55 patients (29.6%) died. The average follow up period was equivalent to 9.24 year per person. A Cox regression model identified four major factors having an impact on survival. History of a stroke at baseline was identified as a major factor (HR=5.33; 95% CI, 2.13-13.32). Statistically significant risk factors were also age over 50 years (HR=4.59; 95% CI, 2.04-10.30); education less than 11 years (HR=3.3; 95% CI, 1.72-6.33) and angina pectoris (HR=1.98; 95% CI, 1.03-3.80).
CONCLUSIONS: Higher age, lower education and cardiovascular comorbidities were identified as predictors of mortality in this prospective cohort study while disease-related variables were not independent predictors of mortality.
Copyright © 2014 Lithuanian University of Health Sciences. Production and hosting by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Cohort study; Comorbidities; Mortality; Predictors; Rheumatoid arthritis

Mesh:

Year:  2014        PMID: 25744772     DOI: 10.1016/j.medici.2014.11.001

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  3 in total

Review 1.  Co-morbidity index in rheumatoid arthritis: time to think.

Authors:  Yasser El Miedany
Journal:  Clin Rheumatol       Date:  2015-10-26       Impact factor: 2.980

2.  Does Regular Use of a Complementary Medicine of Olea Europe and Ficus carica Have Adverse Effects on Lipid Profile and Fasting Blood Glucose of Rheumatoid Arthritis (RA) Patients Under Treatment with DMARD Regimens Containing Methotrexate?

Authors:  Shahnaz Bahadori; Arman Ahmadzadeh; Mohammad Reza Shams Ardekani; Mohammad Kamalinejad; Mansoor Keshavarz; Jamshid Salamzadeh
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

3.  Predicting the Risk of Ischemic Stroke among Patients with Rheumatoid Arthritis Using a Simplified RA-CHADSV Score Based on the CHA2DS2-VASc Score.

Authors:  Chia-Wen Hsu; Khai-Jing Ng; Ming-Chi Lu; Malcolm Koo
Journal:  Medicina (Kaunas)       Date:  2020-02-12       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.